|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2001-4-9
|
|
pubmed:abstractText |
Although supplementation with supraphysiological doses of levothyroxine (T4) has been an effective treatment for refractory affective disorders in open studies, questions remain as to the tolerability of this treatment. This is the first study to investigate subjective patient response and tolerability to long-term treatment with adjunctive T4.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0165-0327
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
64
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
35-42
|
|
pubmed:dateRevised |
2009-9-28
|
|
pubmed:meshHeading |
pubmed-meshheading:11292518-Adult,
pubmed-meshheading:11292518-Cross-Sectional Studies,
pubmed-meshheading:11292518-Dose-Response Relationship, Drug,
pubmed-meshheading:11292518-Drug Administration Schedule,
pubmed-meshheading:11292518-Drug Tolerance,
pubmed-meshheading:11292518-Female,
pubmed-meshheading:11292518-Humans,
pubmed-meshheading:11292518-Hyperthyroidism,
pubmed-meshheading:11292518-Male,
pubmed-meshheading:11292518-Mood Disorders,
pubmed-meshheading:11292518-Questionnaires,
pubmed-meshheading:11292518-Thyroxine,
pubmed-meshheading:11292518-Time
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Subjective response to and tolerability of long-term supraphysiological doses of levothyroxine in refractory mood disorders.
|
|
pubmed:affiliation |
Department of Psychiatry, Klinikum Benjamin Franklin, Freie Universität Berlin, Berlin, Germany. mjbauer@mednet.ucla.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
